drug pricing

A bipartisan group of lawmakers is pressuring the U.S. Department of Health and Human Services (HHS) to intervene in an ongoing dispute between Eli Lilly and hospitals participating in a …

Eli Lilly and Company is changing its distribution strategy for Mounjaro and Zepbound to mitigate what it identifies as “duplicate discounts” involving contract pharmacies. Starting October 1, 2024, the manufacturer …

The U.S. Food and Drug Administration (FDA) has authorized Colorado to import certain prescription drugs from Canada to lower costs for residents, making it the second state to receive such …

Maryland Targets Drug Costs: New Upper Payment Limits for Ozempic Maryland is taking significant steps to address the rising costs of prescription medications. The Maryland Prescription Drug Affordability Board has …

U.K. Advocacy Groups Challenge New Pharmaceutical Trade Deal with U.S.: Risks to Medicine Access and Patient Safety By Dr. Natalie Singh | Health Editor | May 18, 2026 Two prominent …

Trump Administration Intensifies Push for “Most-Favored Nation” Drug Pricing WASHINGTON — Despite a cool reception from Congress, the White House is looking to intensify its pressure campaign on lawmakers to …

Generic Wegovy and Ozempic Could Cost as Little as $3 a Month, Expanding Access Generic versions of Novo Nordisk’s blockbuster medications Wegovy and Ozempic could turn into available for as …

Trump’s Drug Pricing Deals: Three-Year Terms Revealed in SEC Filings WASHINGTON — President Trump’s “most-favored nation” (MFN) deals with pharmaceutical companies, touted as a way to lower prescription drug costs …

In a preemptive move, more than 170 patient advocacy groups from 30 countries are urging Merck to create a global access strategy for an HIV prevention pill, which is still …

Novo Nordisk’s semaglutide Shows Promise in Slowing Cognitive Decline in Alzheimer’s Trial Table of Contents Novo Nordisk’s semaglutide Shows Promise in Slowing Cognitive Decline in Alzheimer’s Trial Trial Details and …